ArticleMethods in molecular biology (Clifton, N.J.)2026
Assay for Transposase-Accessible Chromatin Sequencing (ATAC-seq) of Cancer Cells in Culture.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Assay for Transposase-Accessible Chromatin followed by sequencing (ATAC-seq) is a powerful and widely-used technique for chromatin accessibility profiling due to its low input requirement, simple protocol, high sensitivity, and ability to study single cells. ATAC-seq is a powerful tool in cancer epigenetics research that has enabled the scrutiny of gene regulatory mechanisms, aided the identification of therapeutic targets, and in the exploration of anticancer immunity, thereby advancing our understanding of cancer biology. The protocol includes five main steps: cell isolation and nuclei preparation, Tn5 tagmentation, PCR amplification, library sequencing, and data analysis. Here, we have outlined a comprehensive ATAC-seq protocol that is utilized by our laboratories, along with detailed troubleshooting steps at each point, in the hopes that it will aid other researchers in utilizing this tool to the fullest capability. We also describe bioinformatics pipelines for processing the raw sequence data and identifying regulatory regions by differential accessibility analysis, as well as more advanced methods for the visualization of transcription factor binding sites.
Indexed as
Identifiers
42642593What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.